Judith E. Layton - Concepedia

Author

Judith E. Layton

Also Known As

A A Mahmoud, J E Layton, J Layton, J. E. LAYTON, J. E. Layton, J. LAYTON, J. Layton, J.E Layton, J.E. Layton, JUDITH E. LAYTON

110

Publications

5.8K

Citations

H-Index

Concepts

All Affiliations

Ludwig Cancer Research The Royal Melbourne Hospital Walter and Eliza Hall Institute of Medical Research The University of Melbourne Ludwig Cancer Research

About

Judith E. Layton is an author at Ludwig Cancer Research specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	36	3.3K
2	Allergy	10	10	1.1K
3	Health Sciences	5	5	562
4	Natural Sciences	2	2	69
5	Biochemistry	2	2	42

Judith E. Layton

Publications

5.3K

Citations

H-Index

Page 1

	Year	Citations
Morphologic and functional characterization of granulocytes and macrophages in embryonic and adult zebrafish Graham J. Lieschke, Andrew C. Oates, Meredith O. Crowhurst, Blood	2001	485
GRANULOCYTE COLONY-STIMULATING FACTOR AND NEUTROPHIL RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE MARROW TRANSPLANTATION William Sheridan, M Wolf, Julie Lusk, The Lancet Cell TherapyTransplantationAutoimmune DiseaseMarrow TransplantationBone Marrow Failure	1989	430
Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1. E S Vitetta, J Ohara, Christopher D. Myers, The Journal of Experimental Medicine Lymphocyte DevelopmentBcdf-mu ResponsesHumoral ResponseImmunologyImmune Regulation	1985	409
Continuous plasmafiltration in sepsis syndrome John H. Reeves, Warwick Butt, Frank Shann, Critical Care Medicine	1999	222
Tyrosine kinase JAK1 is associated with the granulocyte-colony-stimulating factor receptor and both become tyrosine-phosphorylated after receptor activation. Sandra E. Nicholson, Andrew C. Oates, Ailsa G. Harpur, Proceedings of the National Academy of Sciences Tyrosine Kinase Jak1ImmunologyImmune RegulationPathologyImmunologic Mechanism	1994	207
Zebrafish SPI-1 (PU.1) Marks a Site of Myeloid Development Independent of Primitive Erythropoiesis: Implications for Axial Patterning Graham J. Lieschke, Andrew C. Oates, Barry H. Paw, Developmental Biology BiologyCell LineageDevelopmental BiologyDevelopmental GeneticsZebrafish Spi-1	2002	203
Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy. George Morstyn, Lynda J. Campbell, Graham J. Lieschke, Journal of Clinical Oncology ImmunologyPharmacotherapyMetronomic ChemotherapyDermatologyImmunotherapy	1989	178
Endogenous haemopoietic growth factors in neutropenia and infection Jonathan Cebon, Judith E. Layton, Darryl Maher, British Journal of Haematology ImmunohematologyImmunodeficienciesImmunologyBone Marrow FailureLaboratory Hematology	1994	176
Growth of B-lymphocyte colonies in vitro. D Metcalf, G. J. V. Nossal, Noel L. Warner, The Journal of Experimental Medicine Semisolid Agar CulturesAllergyAutoimmune DiseaseColony NumbersLymphocyte Development	1975	173
Stromal interaction molecule 1 (STIM1), a transmembrane protein with growth suppressor activity, contains an extracellular SAM domain modified by N-linked glycosylation Richard T. Williams, P. V. Senior, Leonie van Stekelenburg, Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology Extracellular Sam DomainProtein FunctionSignal TransductionGlycobiologyN-linked Glycosylation	2002	145

Page 1